Zum Inhalt springen

Investor Relations

Schwedische Medizintechnik für die Nase – bei der Arbeit, im Alltag und für Ihren Geruchssinn.

Neuester Bericht

Nosa Plugs AB Interim Report for the Third Quarter 2026

6. November 2026

Nächster Termin

Finanzkalender: upcoming dates are published in the interim reports.

Finanzkalender

Videointerviews

Alle Präsentationen

Financial targets

Short-term financial targets – 2025–2026

Growth target
Net sales of at least SEK 50 million in 2026.
Profitability target
Positive EBITDA from Q4 2025 and an EBITDA margin of at least 15 per cent in 2026.

Medium-term financial targets – 2027–2028

Growth target
Average organic net sales growth of at least 25 per cent per year.
Profitability target
EBITDA margin of at least 18 per cent.
Capital structure
Net debt in relation to EBITDA shall not exceed 3 times.
Dividend policy
Surplus shall be distributed to shareholders when free cash flow exceeds available investments in profitable growth. Dividends require that the capital structure target is met.

Going forward, NOSA will also continue to evaluate acquisition opportunities within ear, nose and throat (ENT).

Pressemitteilungen

Alle Pressemitteilungen

Equity Research

Analysen, Kommentare und Interviews zu Nosa Plugs von Analyst Group.

Mehr anzeigen

Quelle: Analyst Group. Wird laufend aktualisiert.

Pressemitteilungen abonnieren

Erhalten Sie Pressemitteilungen und Berichte per E-Mail über MFN.

Abonnieren

IR-Kontakt

Adrian Liljefors

VD

ir@nosaplugs.com

Company details

Company
Nosa Plugs AB (publ)
Address
Surbrunnsgatan 42, 113 48 Stockholm, Sverige
Phone
+46 (0)771 112 000